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Abstract
Background: BioSense is the US national automated biosurveillance system. Data regarding chief complaints and 
diagnoses are automatically pre-processed into 11 broader syndromes (e.g., respiratory) and 78 narrower sub-
syndromes (e.g., asthma). The objectives of this report are to present the types of illness and injury that can be studied 
using these data and the frequency of visits for the syndromes and sub-syndromes in the various data types; this 
information will facilitate use of the system and comparison with other systems.
Methods: For each major data source, we summarized information on the facilities, timeliness, patient demographics, 
and rates of visits for each syndrome and sub-syndrome.
Results: In 2008, the primary data sources were the 333 US Department of Defense, 770 US Veterans Affairs, and 532 
civilian hospital emergency department facilities. Median times from patient visit to record receipt at CDC were 2.2 
days, 2.0 days, and 4 hours for these sources respectively. Among sub-syndromes, we summarize mean 2008 visit rates 
in 45 infectious disease categories, 11 injury categories, 7 chronic disease categories, and 15 other categories.
Conclusions: We present a systematic summary of data that is automatically available to public health departments 
for monitoring and responding to emergencies.
Background
Automated surveillance systems are increasingly being
adopted by public health agencies [1]. A 2007--2008 sur-
vey found that 83% of responding state, territorial, and
large-city health departments in the United States had a
syndromic surveillance system which tracks clinical data,
and that two-thirds were either highly likely or somewhat
likely to expand their use of this modality [2]. Syndromic
surveillance systems are also maintained by the US
Department of Defense (DoD) [3,4], the US Department
of Veterans Affairs (VA), and by several countries other
than the US [5-7]. BioSense, maintained by the Centers
for Disease Control and Prevention (CDC), is the
national automated biosurveillance system used in the
US. This system is intended to improve the nation's capa-
bilities for conducting real-time biosurveillance, and
enabling health situational awareness through access to
existing data from healthcare organizations across the
country [8]. This system automatically receives and ana-
lyzes health data from a variety of sources and provides a
secure web-based application that is available to federal,
state, and local public health and hospital personnel
[9,10].
BioSense was initially developed in 2003 as the early
event detection component of the CDC Public Health
Information Network (PHIN). The system began receiv-
ing national data feeds from VA and DoD outpatient clin-
ics in 2003 and made analyses of these data available
through a web-based application in 2004. In mid-2005,
CDC began to emphasize the concept of situational
awareness, i.e., the ability to monitor the number of ill
p e r s o n s  d u r i n g  a n  o u t b r e a k  o v e r  t i m e  a n d  g e o g r a p h i c
area, regardless of the source of initial event detection. In
late 2005, the program began to receive data from civilian
hospitals. In some cases, the program has created a split
feed, which sends hospital data simultaneously to CDC
and to the applicable state health department. In early
2006, updated methods of data analysis and processing
were developed and presented in a new version of the
application [9]. During 2006--2008, data from several
state and local automated surveillance systems began
flowing to the system; currently, most civilian hospital
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data is received via this mechanism rather than from
individual hospitals or hospital groups. Early attempts
were made to recruit hospitals systematically in major
population areas, but ultimately the facilities included in
the system represent a convenience sample of hospitals,
hospital systems, and state/local systems that are willing
and able to supply appropriate electronic data. Thus, Bio-
Sense has been termed a system of systems.
The term "automated surveillance" includes a range of
activities from syndromic to case-based surveillance.
Syndromic surveillance, using primarily chief complaint
and diagnosis data, provides the capability for simple all-
hazards surveillance. In the context of automated surveil-
lance, case-based surveillance refers to the use of more
specific data types, such as microbiology laboratory
reports, to implement fully electronic case-detection
algorithms [11]. Electronic laboratory reporting, which
automates delivery of laboratory reports but does not
apply a case definition [12,13], might be considered an
intermediate step between syndromic and case-based
surveillance. The case-based approach is promising but
requires substantial additional work before it can be
widely practiced. Currently, information available in
automated systems, including BioSense, consists mostly
of syndromic data.
Analysis of chief complaint and diagnosis data requires
that the records first be assigned to categories, often
called syndromes. The various automated systems use
diverse lists of these concepts[3,14,15]. BioSense-defined
surveillance concepts include broader syndromes and
more-specific sub-syndromes. The 11 syndromes (botu-
lism-like, fever, gastrointestinal, hemorrhagic illness,
localized cutaneous lesion, lymphadentitis, neurological,
respiratory, rash, severe illness or death, specific infec-
tion) were developed in 2003 by a multi-agency working
group to encompass the prodromes of infectious diseases
potentially caused by bioterrorism [16]. In 2006, using
information from the existing systems [3,14], 78 sub-syn-
dromes were defined to permit analysis of more specific
concepts (e.g., cough) and to encompass infectious dis-
eases, injuries, chronic diseases, and ill-defined symp-
toms or exposures [9]. While limited information has
been published on the frequency of syndrome visits [17-
19], comprehensive information on this topic has not
been presented. In this manuscript, we describe the cur-
rent sources of data being reported to this national sys-
tem and present rates of visits meeting syndrome and
sub-syndrome definitions during 2008. These data will
help users to understand the types of illness and injury
that might be studied using the system, give users an idea
of the frequency of visits for the syndromes and sub-syn-
dromes in the various data types, and facilitate compari-
son with other systems.
Methods
Data sources included in this analysis are DoD Military
Treatment Facilities outpatient clinics; VA outpatient
clinics; and civilian hospital outpatient clinics, emergency
departments (EDs), and inpatient facilities (Table 1). All
US DoD and VA facilities, but only some civilian facili-
ties, provide data. The DoD data are primarily from out-
patient clinics; however, approximately 15% of the visits
were from patients seen in emergency facilities. These
visits can not currently be differentiated in BioSense.
From the DoD and VA clinics, only International Classifi-
cation of Diseases, 9th Revision, Clinical Modification
(ICD-9CM) coded final diagnoses are sent. Civilian facili-
ties may send chief complaints, working (preliminary)
diagnoses, and final diagnoses. Additional clinically rich
data (i.e., microbiology laboratory, radiology text reports)
are received from a subset of civilian hospitals but are not
i n c l u d e d  i n  t h i s  r e p o r t .  A l l  B i o S e n s e  d a t a  c o m e  f r o m
existing databases used by the data sources for adminis-
trative or clinical purposes; no data are specifically
entered into a database for this project.
All data sources submit limited demographic informa-
tion (i.e., age, gender). While patient names and other
identifiers are not received, for the VA and some civilian
hospitals, a random number identifier (Patient ID) is
included and permits linking data from an individual
patient across multiple visits. The records for linking this
Patient ID with identifiable patient data is stored in a
database at the data source and can be accessed only by
authorized personnel there. Incoming data are routinely
monitored for completeness of data fields and consis-
tency with the number of records routinely received from
each data sources, and problems are corrected by work-
ing with the applicable data source; however, such checks
can identify only large-scale problems and more detailed
checking for data accuracy is beyond current capabilities.
ICD-9CM coded diagnoses are assigned to 1 or more of
the 11 syndromes as per the 2003 working group docu-
ment [16] and are separately assigned to sub-syndromes
according to a reference table developed by CDC [9]. The
same visit may be classified as showing >1 disease indica-
tor; for example, a visit with a chief complaint of "asthma
and shortness of breath" will be included in both the
asthma and dyspnea categories. However, counts from
these 2 categories are analyzed separately and not added
together. Free-text chief complaints and diagnoses are
first assigned to sub-syndromes and then the sub-syn-
dromes assigned to syndromes. The free-text data are
automatically parsed for specified keywords. For exam-
ple, chief complaint keywords for the asthma sub-syn-
drome include "asthma," "bronchospasm," "chest tight,"
"reactive airway disease," "status asthmaticus," and mis-
spellings and abbreviations for these terms. The referenceTokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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tables, available from the authors, include: ICD-9CM
diagnosis to syndrome, ICD-9CM diagnosis to sub-syn-
drome, free-text diagnosis to sub-syndrome, free-text
chief complaint to sub-syndrome, and sub-syndrome to
syndrome. The specific infection syndrome, which
includes acute infection of known cause not covered in
other syndrome groups, is used for diagnoses but not for
chief complaints. A given diagnosis or chief complaint
may be assigned to 1 or more syndromes and sub-syn-
dromes. While visits may have >1 diagnosis listed, only
some facilities send reliable data indicating which is the
primary diagnosis; therefore, currently all diagnoses are
assigned to syndromes and sub-syndromes, without an
attempt to determine which is the primary reason for the
visit.
For most analyses, data from January 1--December 31,
2008, are summarized in this report. Facilities submitting
information on ≥1 visit during ≥50% of the days during
this period are included. The number of visits meeting
each syndrome and sub-syndrome definition was deter-
mined and the rates per 1000 total visits were tabulated.
"Total visits" refers to the total number of patient visits
and includes visits both assigned and not assigned to a
syndrome/sub-syndrome. The rate per 1000 total visits is
more informative than simple numerator count data (e.g.,
10 visits for respiratory illness has a different meaning
among 50 vs. 500 total visits), and is more appropriate
than rates per total population, since the system does not
capture visits from the total population. Age, gender, and
time to record receipt were determined from data
reported in December 2008. We determined the median
time from each visit to receipt at CDC by subtracting the
date and time of visit as reported by the data source from
the date/time stamp assigned by CDC computers when
the message was received at CDC.
Results
During 2008, data were received from 333 DoD and 770
VA facilities (Table 1). Among civilian hospitals, ED chief
complaint data was received from 532 hospitals and ED
final diagnosis data from 203; data from outpatients and
inpatients were received from a smaller number of facili-
ties. Reported visits totaled 32.9 million for the DoD, 54.4
million for the VA, and 18.1 million for hospital ED chief
complaints. The median number of visits per facility per
weekday was 148 for the DoD, 48 for the VA, and 76 for
Table 1: Primary data source, visit, and patient characteristics, BioSense, January-December 2008.
Data Source and Type No. of facilities Total visits, 
millions








DoD Outpatient Final 
Diagnosis
333 32.9 148, 34 2.2 days 29 43.5
VA Outpatient Final 
Diagnosis
770 54.4 48, 33 2.0 days 61 7.2
Civilian Hospitals 
Outpatient
Chief Complaint 85 4.6 121, 12 0.3 hour 52 64.8
Working Diagnosis 62 1.8 44, 4 4.6 days 53 64.2
Final Diagnosis 72 2.7 64, 7 5.1 days 51 62.7
Civilian Hospitals ED
Chief Complaint 532 18.1 76, 9 4 hours 35 55.8
Working Diagnosis 105 2.4 51, 55 1.8 days 35 56.1
Final Diagnosis 203 6.3 66, 70 5.1 days 35 56.4
Civilian Hospital 
Inpatient
Chief Complaint 115 1.7 32, 18 4 hours 50 59.3
Working Diagnosis 78 0.8 22, 13 8.1 days 51 58.1
Final Diagnosis 81 1.1 27, 16 9.9 days 47 59.2
DoD denotes Department of Defense, VA denotes Veterans Administration, ED denotes emergency department.
* Values are for weekdays, weekends.
† Time from patient visit to receipt of data at CDC.
‡ For these columns, data is from December 2008.Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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hospital ED chief complaint. Markedly fewer visits
occurred on the weekends for the DoD, VA, and civilian
hospital outpatient clinics.
Median time to receipt of data at CDC was lowest for
outpatient chief complaints (0.3 hour) and highest for
hospital inpatient final diagnosis (9.9 days) (Table 1). For
ED chief complaints, median time to receipt was 4 hours,
but varied from 17 minutes if the data were sent directly
from the hospital to CDC to 9.4 hours if the data were
sent via a state or local system. Median age was lowest for
DoD clinics (29 years) and highest for VA clinics (61
years). For most data sources, a majority of visits were
made by females (e.g., ED chief complaint data 55.8%
female), except for the DoD and VA clinics (43.5% and
7.2% female, respectively).
At least 1 facility is located in each of the 50 states for
the VA, in 47 states for the DoD, and in 25 states for civil-
ian hospitals (Figures 1, 2 and 3). Civilian hospitals are
clustered in certain states (Illinois, Indiana, Michigan,
Missouri, North Carolina, Ohio, and Texas) having strong
state or local systems that share data with BioSense. The
number of VA and DoD facilities providing data has been
similar each year, but the number of civilian hospitals
providing data has increased from 331 in December 2006,
to 534 in December 2007, and to 566 in December 2008
(data not shown).
Among the 11 syndromes, rates of ED chief complaint
visits were highest for respiratory (205.6 per 1000) and
gastrointestinal (144.0) and lowest for severe illness and
death (0.3) (Table 2). These syndromes are also highest
and lowest for other data sources. For a given syndrome,
visit rates varied markedly among the data categories,
e.g., the fever syndrome rate was highest for ED chief
complaints (59.1) and lowest for VA final diagnosis (0.8).
In part, this variability is due to differences in the refer-
ence tables used for chief complaints vs. diagnoses, the
numbers of facilities reporting for each data type, and the
numbers of chief complaints or diagnoses reported per
visit. Lower rates for the civilian outpatient and VA may
reflect the reality that many visits in these settings are for
chronic disease follow-up rather than for acute disease
treatment which would be reflected in the syndromes.
Of the 78 sub-syndromes, 45 are classified under the
infectious disease syndromes (Table 3). Fourteen sub-
syndromes are classified under the respiratory syndrome,
7 under the neurological syndrome, and smaller numbers
under other syndromes. Among ED chief complaint vis-
its, the highest rates were for abdominal pain (82.9 per
1000), chest pain (72.0), and nausea and vomiting (65.3).
Among ED final diagnosis visits, the highest rates were
for abdominal pain (81.4), chest pain (63.5), and upper
respiratory infection (59.1). As expected, sub-syndromes
that capture symptom concepts had higher rates for chief
complaints than for diagnoses; e.g., for ED data, the dysp-
nea (shortness of breath) rate was 52.2 for chief com-
plaints vs. 28.4 for diagnoses. The converse was true for
sub-syndromes that capture diagnostic concepts; e.g., the
asthma rate is 46.5 for diagnoses vs. 12.7 for chief com-
plaints. Sub-syndromes reflecting more severe disease
had higher rates in inpatients: e.g., the diagnosis rate for
pneumonia was 47.3 for inpatients, 19.3 for ED patients,
and 4.0 for outpatients.
Thirty-three of the sub-syndromes do not fall under a
syndrome category, including 11 injury concepts, 7
chronic disease concepts, and 15 other concepts (Table
4). Among the injury sub-syndromes, the most com-
monly reported ED chief complaints were injury not oth-
erwise specified (rate 71.0 per 1000 visits), falls (36.5),
and open wounds (32.1); the most common diagnoses
were sprains and strains (58.5), falls (57.7), and fractures
and dislocations (37.1). Among the chronic disease con-
cepts, hospital inpatient diagnoses had the highest rates,
with hypertension, diabetes mellitus, and ischemic heart
disease most frequent; however, such concepts are gener-
ally not the primary reason for the visit. Among the 15
other concepts, the most common ED chief complaints
were dizziness (rate 19.7 per 1000 visits), malaise and
fatigue (19.0), and edema (16.4).
Discussion
BioSense is a system-of-systems, with data being received
from federal partners, existing health department sys-
tems, hospital systems, and individual hospitals. In 2008,
the primary data sources were 532 civilian hospital EDs,
333 DoD facilities, and 770 VA facilities. These data
sources vary markedly in their geographic coverage, pop-
ulation coverage, demographics, and timeliness of report-
ing. Demographically, visits to BioSense EDs are
reasonably representative of the U.S ED population
[20,21]; DoD visits, which are made by active duty per-
sonnel, retired persons, and family members, represent a
younger population with a higher proportion of males;
and VA visits represent an older and heavily male popula-
tion. Since 2006, most of the growth in the system has
been through receipt of data from existing state or local
health department systems that provide ED chief com-
plaint data. Time from patient visit to data receipt at
CDC was shortest for civilian hospital chief complaint
data, especially if the data was sent directly from the hos-
pital rather than via a state or local system. A detailed
comparison of ED data from BioSense with a nationally
representative survey performed by the National Center
for Health Statistics is underway [20,21]. However, the 2
most common reasons for visit (abdominal pain and
chest pain) are the same in both systems. We estimate
that in 2008 BioSense captured chief complaints from
about 14--15% of all US ED visits.Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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We have summarized visit rates for both the broader
syndromes and narrower sub-syndromes. Because they
capture more specific concepts, sub-syndromes may be
more useful. For example, during a 3-day period of smoke
exposure due to wildfires in San Diego in October 2007,
ED chief complaint visits increased 22% above the previ-
ous 28 days for the respiratory syndrome; in comparison,
increases were larger for 2 respiratory sub-syndromes,
dyspnea (50%) and asthma (182%) [22]. Automated sur-
veillance was originally geared to infectious diseases, and
many of the sub-syndromes fall under infectious catego-
ries such as respiratory and gastrointestinal. However, we
also include sub-syndromes related to injuries, chronic
diseases, and a number of general concepts not fitting in
any of the above categories (i.e., malaise and fatigue). The
breadth of concepts that can be monitored, albeit in a
simple manner, is a strength of this system.
At least 3 methods are commonly used to make syn-
drome assignments from chief complaint data. The Real-
Time Outbreak Detection System (RODS), which uses 7
syndromes, employs a training dataset of ED records
which have been assigned manually to syndromes by
experts; this dataset then is used to train CoCo, a naïve
Bayesian classifier, to make the free-text chief-complaint-
to-syndrome assignment during production data analysis
[15]. The Early Notification of Community-Based Epi-
demics (ESSENCE) system, which uses variable numbers
of syndromes and sub-syndromes in different versions,
first normalizes the text to remove punctuation and
expand abbreviations and then assigns the normalized
text to a concept using human-assigned weights [3].
Other systems, including the Early Aberration Reporting
System (EARS) [14] and the New York City system [18],
use a text-parsing method, similar to that used by Bio-
Sense, which scans for keywords, misspellings, and
abbreviations and then makes the category assignments.
In comparing BioSense with other commonly-used
automated surveillance systems such as EARS,
ESSENCE, or RODS, it is useful to distinguish between
the BioSense program, which supports a number of activ-
ities including collation of numerous data types from
around the U.S., vs. the BioSense application, which dis-
plays data and analyses. Other systems do not have a
function comparable to the BioSense program, but
instead provide software tools for a locality to analyze its
own data. In comparison with the BioSense application,
other systems use different surveillance concepts (as
noted above), different statistical methods for finding
data anomalies, and different interfaces for displaying
results. An evaluation of the sensitivity and specificity of
statistical methods used in BioSense has been published
[19]; this includes a comparison with methods used in
EARS but not with those used in other systems. A study
funded by BioSense found that, because of greater famil-
Figure 1 Location of 532 civilian hospitals providing emergency department chief complaint data to BioSense, 2008.Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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iarity and engagement, epidemiologists generally pre-
ferred to use systems that they developed rather than the
BioSense application [23]; these results are useful as
plans, outlined in the Conclusion, are being made to
revise the BioSense program.
The BioSense program includes a number of activities
not otherwise described in this manuscript. The BioIntel-
ligence Center, composed of several analysts, reviews the
data daily and provides reports to state and local health
departments and to the CDC Emergency Operations
Center. A specialized Influenza Module [24,25] summa-
rizes data from 3 traditional sources supplied by the
Influenza Division at CDC [26], and from 5 automated
sources via BioSense. The sub-syndrome designated
"influenza-like illness" captures free-text data that men-
tion "flu" or "influenza" and ICD-9CM codes of 487; how-
ever, the Influenza Module uses the following
combination of sub-syndromes for influenza surveillance:
influenza-like illness or (fever and cough) or (fever and
upper respiratory infection). Computer infrastructure
installed by CDC is used to forward notifiable disease
laboratory data to state health departments from 40 hos-
pitals and 1 national laboratory. Plans to enable messag-
ing from a second national laboratory are in progress. In
addition, funding has also been provided to support orig-
inal research, evaluation of syndromic surveillance and
BioSense [23], and awards to the Centers of Excellence in
Public Health Informatics [27].
Evaluation of the validity of the data received by auto-
mated systems is difficult, but a number of points support
the validity of BioSense data. When new data sources are
added, a one-week sample of data are scanned by techni-
cal personnel for data quality problems and adherence to
data dictionary standards; thereafter, if the typical num-
ber of incoming records changes, corrective action is
taken. As part of a BioSense-funded cooperative agree-
ment, a validation of >9,000 records from two North Car-
olina hospitals showed >99% agreement with data
received by CDC [28]. Biologically plausible increases in
visits have been found for asthma associated with a wild-
fire [22], falls associated with winter weather [29], and
burns associated with Independence Day [30]. Seasonal
trends in influenza-like illness [25], heat injury [31],
asthma [32], and gastrointestinal disease [33] follow
expected patterns. Finally, a number of 1-day increases in
visits at single hospitals have been linked via newspaper
reports or personal communications to known incidents
[34]; on three occasions, such increases were due to artifi-
cial records introduced into hospital ED systems during
preparedness drills (unpublished information).
Figure 2 Locations of 770 Veterans Affairs outpatient clinics providing data to BioSense, 2008.Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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Figure 3 Locations of 333 Department of Defense Military Treatment Facilities providing data to BioSense, 2008.
Table 2: Visit rates per 1000 total visits for 11 syndromes by data source, patient class, and data type, BioSense, January-
December 2008.
Syndrome ED CC ED FD IP CC IP FD OP CC OP FD DoD FD VA FD
Botulism-like 2.9 7.2 3.9 17.3 4.5 3.4 1.4 5.2
Fever 59.1 47.6 27.9 36.9 7.1 5.8 7.8 0.8
Gastrointestinal 144.0 136.2 61.3 77.1 39.6 43.8 22.8 9.6
Hemorrhagic illness 25.1 15.7 26.8 41.7 10.0 6.6 2.9 5.7
Localized cutaneous lesion 23.4 30.6 19.1 35.7 4.0 9.0 6.2 6.5
Lymphadenitis 0.5 3.9 0.6 4.8 0.4 3.3 1.4 0.6
Neurological 53.7 53.2 27.1 35.9 11.6 14.2 7.8 8.1
Respiratory 205.6 233.8 129.1 199.2 62.9 80.2 73.0 26.9
Rash 19.9 14.9 0.8 8.4 2.5 5.3 9.7 5.8
Severe illness or death 0.3 2.8 2.1 3.2 0.7 0.2 0.0 0.0
Specific infection --* 19.4 --* 31.6 --* 4.1 6.5 3.0
Abbreviations: CC, chief complaint; ED, hospital emergency department; FD, final diagnosis; DoD, Department of Defense; IP, hospital inpatient; 
OP, hospital outpatient; VA, Veterans Affairs.
*Chief complaints are not included in the specific infection syndrome.Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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Table 3: Sub-syndromes associated with infectious disease syndromes: visit rates per 1000 total visits by data source, 
patient class, and data type, January-December 2008.
Syndrome Sub-syndrome ED CC ED FD IP CC IP FD OP CC OP FD DoD FD VA FD
Botulism-like
Dysphagia 0.9 1.5 1.5 13.6 3.8 3.7 0.9 1.9
Paralysis 1.2 2.0 1.6 10.0 0.5 1.1 0.3 3.0
S p e e c h  d i s t u r b a n c e 0 . 91 . 80 . 96 . 70 . 30 . 70 . 20 . 7
Fever
Fever 58.2 31.5 18.4 14.9 6.8 4.9 3.7 0.6
Septicemia 0.6 5.4 10.6 28.5 0.3 0.6 0.5 0.2
Viral infection, unspecified 1.6 16.4 0.3 4.7 0.1 1.5 4.2 0.2
Gastrointestinal
Abdominal pain 82.9 81.4 36.7 23.4 27.3 29.0 9.0 4.5
Anorexia 1.4 1.6 0.4 3.5 0.2 0.3 0.2 0.2
Diarrhea 16.1 18.6 5.8 14.0 4.4 5.2 3.3 2.0
F o o d  p o i s o n i n g 0 . 30 . 20 . 10 . 40 . 00 . 00 . 10 . 0
Intestinal infection 1.0 1.9 5.1 0.9 0.6 0.3 0.1 0.1
Nausea and vomiting 65.3 54.3 19.2 18.4 6.0 5.9 4.8 1.1
Hemorrhagic illness
C o a g u l a t i o n  d e f e c t s 0 . 11 . 41 . 56 . 40 . 12 . 10 . 22 . 3
Gastrointestinal hemorrhage 5.9 5.5 11.1 10.7 1.4 2.4 1.5 1.8
Hemorrhage 21.7 1.8 22.6 1.9 9.3 0.1 0.0 0.1
Purpura and petechia 0.1 2.7 0.2 19.6 0.1 2.1 0.6 1.1
Localized cutaneous lesion
I n s e c t  b i t e s 6 . 03 . 60 . 11 . 20 . 40 . 31 . 00 . 3
Skin infection 17.9 31.6 19.1 31.1 3.7 5.8 7.0 4.6
Lymphadenitis
L y m p h a d e n o p a t h y 0 . 52 . 80 . 64 . 10 . 43 . 01 . 10 . 6
Neurological
Alteration of consciousness 9.9 4.0 11.7 6.1 2.1 0.7 0.3 0.2
C N S  i n f l a m m a t o r y  d i s e a s e 0 . 31 . 81 . 22 . 20 . 30 . 30 . 20 . 1
Convulsions 9.9 10.5 8.4 10.7 2.6 4.2 0.5 3.1
G a i t  a b n o r m a l i t y 0 . 91 . 40 . 27 . 70 . 42 . 31 . 02 . 9
Headache 33.2 39.1 6.5 13.9 6.4 9.0 6.4 4.5
M e n i n g i s m u s 0 . 60 . 00 . 10 . 10 . 10 . 00 . 00 . 0
P h o t o p h o b i a 0 . 31 . 90 . 00 . 20 . 00 . 00 . 10 . 2
Respiratory
Asthma 12.7 46.5 7.9 60.0 5.1 15.3 8.9 5.7
Bronchitis and bronchiolitis 1.6 26.7 4.2 14.5 1.5 4.0 6.7 1.6
Chest pain 72.0 63.5 51.0 37.8 16.6 17.2 5.9 7.2
Cough 38.3 27.1 2.9 5.5 13.7 12.9 4.7 3.1
Cyanosis and hypoxemia 0.7 3.5 6.5 19.9 0.5 0.9 0.3 0.5
Dyspnea 52.2 28.4 34.7 15.0 13.6 16.8 4.6 5.5
Hemoptysis 1.5 1.2 0.9 2.9 0.3 0.5 0.1 0.3
I n f l u e n z a - l i k e  i l l n e s s 5 . 94 . 90 . 82 . 00 . 50 . 40 . 50 . 2
Otitis media 16.2 21.9 0.8 6.9 2.4 4.4 10.1 1.3
Pleurisy 0.5 4.2 2.4 18.1 1.0 2.7 0.4 0.6
Pneumonia 3.7 19.3 26.6 47.3 3.8 4.0 3.6 0.1
Respiratory failure 0.3 8.0 8.7 35.8 0.1 8.2 0.5 1.3
R e s p i r a t o r y  s y n c y t i a l  v i r u s 0 . 30 . 91 . 42 . 60 . 10 . 20 . 20 . 0
Upper respiratory infection 36.5 59.1 2.9 17.9 9.6 11.7 35.5 4.4
Rash
R a s h 1 9 . 99 . 50 . 83 . 42 . 52 . 92 . 42 . 1Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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Severe illness or death
Coma 0.2 0.2 0.7 1.2 0.8 0.0 0.0 0.0
D e a t h 0 . 30 . 50 . 80 . 10 . 10 . 00 . 00 . 0
S h o c k 0 . 11 . 30 . 89 . 80 . 10 . 10 . 10 . 0
Specific infection
Specific infection -- 19.4 -- 31.6 -- 4.1 6.5 3.0
Abbreviations: CC, chief complaint; ED, hospital emergency department; FD, final diagnosis; DoD, Department of Defense; IP, hospital inpatient; 
OP, hospital outpatient; VA, Veterans Affairs.
Table 3: Sub-syndromes associated with infectious disease syndromes: visit rates per 1000 total visits by data source, 
patient class, and data type, January-December 2008. (Continued)
Table 4: Sub-syndromes not associated with syndromes: visit rates per 1000 total visits, by data source, patient class, and 
data type, January-December 2008.
Category Sub-syndrome ED CC ED FD IP CC IP FD OP CC OP FD DoD FD VA FD
Injury
Bites, animal 6.8 6.6 0.5 2.0 0.6 0.5 0.7 0.2
Burns 3.2 3.7 1.1 1.8 0.7 0.8 0.9 0.3
Carbon monoxide poisoning 0.2 0.2 0.1 0.1 0.0 0.1 0.0 0.0
Falls 36.5 57.7 5.9 30.4 2.3 5.3 3.0 1.3
Fractures and dislocations 4.4 37.1 22.7 30.8 7.7 14.5 10.5 5.0
Heat, excessive 0.3 0.6 0.1 0.3 0.0 0.1 0.2 0.0
Injury, not otherwise specified 71.0 30.2 8.1 4.3 7.4 4.4 1.5 2.0
Motor vehicle traffic 22.7 28.9 2.7 9.0 1.0 1.3 1.0 0.2
Open wound 32.1 25.3 7.1 8.4 1.2 1.8 1.7 0.7
Poisoning by medicine 4.0 4.8 2.5 6.5 0.2 0.4 0.3 0.1
Sprains and strains 2.4 58.5 1.0 9.4 2.2 7.7 22.0 4.0
Chronic diseases
Cardiac dysrhythmias 5.0 32.4 8.8 118.3 7.8 22.5 6.9 30.7
Cerebrovascular disease 3.9 10.8 18.1 43.3 3.7 9.8 1.6 6.8
COPD 1.5 10.9 12.1 27.2 3.4 2.5 0.6 2.3
Diabetes mellitus 5.7 68.5 14.7 144.1 9.2 65.1 17.8 92.9
Heart disease, ischemia 2.2 36.2 24.4 132.5 8.7 21.6 3.7 36.4
Hypertension 8.5 128.4 14.8 244.5 34.0 96.8 31.8 124.4
Neoplasms 1.4 26.8 33.1 95.8 30.0 78.5 18.7 35.0
Other
Anemia 1.0 24.6 12.9 143.7 7.7 26.7 5.7 15.9
Dehydration 2.9 20.2 14.8 54.2 0.8 2.6 1.3 0.6
Dizziness 19.7 16.0 5.0 6.9 3.7 5.3 2.4 3.4
Edema 16.4 4.7 3.8 7.0 6.9 4.7 0.8 4.2
Hypotension 1.3 5.4 4.8 29.7 2.1 0.8 0.4 1.3
Jaundice 0.3 0.5 1.3 1.9 1.6 0.4 0.1 0.2
Malaise and fatigue 19.0 13.6 1.7 10.7 5.2 11.1 2.3 1.8
Mental disorders 6.2 168.2 1.2 236.9 0.5 49.0 80.7 211.3
Migraine 5.8 13.1 0.5 11.3 0.7 2.2 4.8 2.9
Myalgia 4.1 9.7 0.3 7.7 0.7 2.9 3.0 2.4
Numbness 9.0 8.2 2.1 4.8 2.1 3.3 1.8 1.8
Pregnancy, childbirth 11.5 25.0 89.5 98.9 17.4 27.0 15.1 0.1
Syncope and collapse 12.0 12.6 13.3 12.7 2.5 3.0 1.5 1.4
Urinary tract infect 6.3 43.8 14.2 62.6 6.9 13.1 6.4 3.0
Visual impairment 2.2 1.3 0.6 5.1 0.9 0.6 0.2 4.1
Abbreviations: CC, chief complaint; ED, hospital emergency department; FD, final diagnosis; DoD, Department of Defense; IP, hospital inpatient; 
OP, hospital outpatient; VA, Veterans Affairs.Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
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Limitations of this study include representation of only
a convenience sample of civilian hospitals and an inability
to perform detailed comparisons of visits at individual
facilities with data received by the system. The rates per
1000 total visits presented represent proportional mor-
bidity at facilities providing data rather than population-
based incidence. Caution should be used in comparing
these rates among the data sources because of differences
in the numbers of facilities reporting, varying numbers of
chief complaints or diagnoses provided per visit, and the
use of different reference tables used to assign chief com-
plaints vs. diagnoses to syndromes and sub-syndromes.
There is potential misclassification because of limitations
of patient-reported chief complaints, which are subjec-
tive, and diagnosis codes, which have well-recognized
limitations. Additionally, the same patient may contribute
>1 visit on different days, and follow-up visits for recheck
may be particularly high in systems such as the DoD
where patients do not have to pay for such visits. While
the same visit may be classified as showing >1 disease
indicator, counts from these 2 categories are analyzed
separately and not added together. BioSense, like other
automated systems, can monitor seasonal influenza
activity [24,25] and recognize large increases in visits for
some general surveillance concepts; however, a more sub-
stantial contribution to public health practice awaits the
ability to access data that is more specific than chief com-
plaints and diagnoses. Nevertheless, to our knowledge
this report presents the largest collation of automated
surveillance data yet assembled.
During its first 6 years of operation, the system has had
a number of problems, most of which have been cor-
rected or will be addressed in the near future. First, cer-
tain key variables, e.g., diagnosis priority at hospital
facilities, and clinic type and patient identifier at DoD
facilities, either were not available or were inadvertently
excluded. During 2003--2006, the application displayed
sentinel alerts based on ICD-9CM coded diagnoses from
the VA and DoD systems, in some cases due to miscodes
at the facility such as "plaque" being coded as "plague."
Current processes avoid this problem. During 2005--
2006, program insistence on receipt of data directly from
hospitals was expensive and created resentment among
some state and local health departments; the current
approach emphasizing access to data through existing
state or local systems or Health Information Exchanges is
more fruitful. A number of problems have been identified
in chief complaints and diagnosis mapping tables, e.g.,
"sore throat" being assigned to the localized cutaneous
lesion syndrome because of the word "sore." The Bio-
Sense application has expanded functionality but lacks
key features such as the ability to perform free-text
searches or to create custom syndromes using terms such
as "fever and cough." The capability to share datasets with
health departments and research partners is hampered by
data use agreements as well as technical issues. Finally,
procedures for data receipt, warehousing, and pre-pro-
cessing have not been flexible enough to allow revisions
to be made quickly.
Conclusions
We present the first systematic summary of data that is
currently being received by the CDC BioSense program.
This data is automatically processed and made available
to public health departments for monitoring and
responding to emergencies. This summary should help
users and policy-makers understand the current uses and
limitations of the data, and contribute to efforts to
improve the field of automated surveillance. BioSense is
being extensively revised to advance nation-wide real
time biosurveillance capability and capacity. Principles
will include continued expansion of biosurveillance
capacity through fostering state and local systems,
replacement of the national datasets currently main-
tained by CDC with a series of jurisdiction-specific data-
sets created and maintained by state and local systems
(federated data model), continued promotion of elec-
tronic laboratory reporting, and increasing use of inex-
pensive, light-weight, software tools. In upcoming years,
these initiatives will continue to expand the scope and
utility of automated surveillance systems.
Abbreviations
CC, chief complaints; CDC, Centers for Disease Control and Prevention; COPD,
Chronic obstructive pulmonary disease; DoD, Department of Defense; ED, hos-
pital emergency department; FD, final diagnosis; ICD-9CM, International Classi-
fication of Diseases, 9th Revision, Clinical Modification; IP, hospital inpatient; OP,
hospital outpatient; PHIN, Public Health Information Network; VA, Veterans
Affairs
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
All authors read and approved the final manuscript. JT planned the project,
designed the data tables, and drafted the manuscript. RE designed the analytic
datasets, analyzed data, and edited the manuscript. PM created datasets for
analysis and assisted with data analysis. BR provided overall guidance for the
project and assisted with manuscript preparation
Acknowledgements
We gratefully acknowledge the following people who were instrumental in 
establishing this system: Colleen Martin, Leslie Lenert, John Loonsk, Henry 
Rolka, Lyn Steele, and David Walker. We acknowledge the BioIntelligence Cen-
ter analysts Kaipo Akaka, Jacqueline Burkholder, Mathew Miller, Keydra Phillips, 
Sule Mohamed, and Gabrial Rainisch for multiple contributions to the system 
and Matt Miller and Peter Hicks for assistance in making the maps. We 
acknowledge Julie Pavlin and Kenneth Cox for reviewing and revising the man-
uscript.
We acknowledge the following groups that further national preparedness by 
sharing data with BioSense: Alegent Health, Aurora Health Care Corporate 
Office, Banner Health, Baylor Health Care System, Beth Israel Deaconess Medi-
cal Center, BJC Healthcare, Children's Hospital Boston, Children's Hospital Los 
Angeles, CHRISTUS Health, Cook Children's Health Care System, Cook County 
Bureau of Health, Cook County Department of Public Health, the Department 
of Defense, the Department of Veterans Affairs, Denver Health and Hospital Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
http://www.biomedcentral.com/1472-6947/10/30
Page 11 of 12
Authority, Georgia Division of Public Health, Gwinnett Health System, Indiana 
State Department of Health, Johns Hopkins Hospital and Health System, Lab-
Corp Laboratories, MedStar Health, Methodist Healthcare, Michigan Depart-
ment of Community Health, Missouri Department of Health/Senior Services, 
Mount Carmel Health System, NC Detect, Ohio Department of Health, Oregon 
Health Sciences University, Quest Diagnostic Services, Relay Health, Saint 
Luke's Health System, Sentara Healthcare, Sharp HealthCare, Sierra Providence 
Health Network, Tarrant County Advanced Practice Center, Tenet Healthcare 
Corporation, Thomas Jefferson University Hospital, University of California San 
Diego Medical Center, and University Medical Center Las Vegas.
Disclaimer
The findings and conclusions in this report are those of the authors and do not 
necessarily represent the official positions of the Centers for Disease Control 
and Prevention or the Department of Defense.
Author Details
The National Center for Public Health Informatics, Centers for Disease Control 
and Prevention, Atlanta, Georgia, USA
References
1. Mandl KD, Overhage JM, Wagner MM, Lober WB, Sebastiani P, Mostashari 
F, et al.: Implementing syndromic surveillance: a practical guide 
informed by early experience.  J Am Med Inform Assoc 2004, 11:141-150.
2. Buehler JW, Sonricker A, Paladine M, Soper P, Mostashari F: Syndromic 
surveillance practice in the United States: findings from a survey of 
state, territorial, and selected local health departments.  Advances in 
Disease Surveillance 2008, 6:1-8.
3. Lewis MD, Pavlin JA, Mansfield JL, O'Brien S, Boomsma LG, Elbert Y, et al.: 
Disease outbreak detection system using syndromic data in the 
greater Washington DC area.  Am J Prev Med 2002, 23(3):180-6.
4. Marsden-Haug N, Foster VB, Gould PL, Elbert E, Wang H, Pavlin J: Code-
based syndromic surveillance for influenza-like illness by International 
Classification of Diseases, Ninth Revision.  Emerg Infect Dis 2007, 
13:207-216.
5. Watkins RE, Eagelson S, Veenendall B, Wright G, Plant AJ: Applying 
cusum-based methods for the detection of outbreaks of Ross River 
virus disease in Western Australia.  BMC Medical Informatics and Decision 
Making 2008, 8:1-11.
6. Vergu E, Grais RF, Sarter H, Fagot J-P, Lambert B, Valleron A-J, Flahault A: 
Medication sales and syndromic surveillance, France.  Emerg Infect Dis 
2006, 12:416-421.
7. Edge VL, Pollari F, Lim G, Aramini J, Sockett P, Martin SW, Wilson J, Ellis A: 
Syndromic surveillance of gastrointestinal illness using pharmacy 
over-the-counter sales: a retrospective study of waterborne outbreaks 
in Saskatchewan and Ontario.  Can J Pub Health 2004, 95:446-450.
8. Centers for Disease Control and Prevention: About BioSense.   [http://
www.cdc.gov/BioSense]. Updated: September 14, 2009, accessed 1/12/
2010
9. Science Applications International Corporation: BioSense Real-Time 
Hospital Data User Guide, Version 2.11 (November 2007).   [http://
www.yellowdocuments.com/3272271-biosense-real-time-hospital-da]. 
Atlanta, GA: Centers for Disease Control and Prevention
10. Centers for Disease Control and Prevention: BioSense: Implementation 
of a National Early Event Detection and Situational Awareness System.  
MMWR 2005, 54(1):11-19.
11. Centers for Disease Control and Prevention: Automated detection and 
reporting of notifiable diseases using electronic medical records 
versus passive surveillance--Massachusetts, July 2006--July 2007.  
MMWR 2008, 57(14):373-376.
12. Effler P, Ching-Lee M, Bogard A, Ieong M, Nekomoto T, Jernigan D: 
Statewide system of electronic notifiable disease reporting from 
clinical laboratories comparing automated reporting with 
conventional methods.  JAMA 1999, 282(19):1845-1850.
13. Overhage JM, Grannis S, McDonald CJ: A comparison of the 
completeness and timeliness of automated electronic laboratory 
reporting and spontaneous reporting of notifiable conditions.  Am J 
Public Health 2008, 98(2):344-350.
14. Hutwagner L, Thompson W, Seeman GM, Treadwell T: The bioterrorism 
preparedness and response Early Aberration Reporting System (EARS).  
J Urban Health 2003, 80(2, suppl 1):i89-i96.
15. Chapman WW, Dowling JN, Wagner MM: Classification of emergency 
department chief complaints into 7 syndromes: a retrospective 
analysis of 527,228 patients.  Ann Emerg Med 2005, 46:445-55.
16. Centers for Disease Control and Prevention: Syndrome definitions for 
diseases associated with critical bioterrorism-associated agents, 
October 23, 2003.   [http://www.bt.cdc.gov/surveillance/syndromedef/
index.asp].
17. Lazarus R, Kleinman K, Dashevsky I, Adams C, Kludt P, DeMaria A, et al.: Use 
of automated ambulatory-care encounter records for detection of 
acute illness clusters, including potential bioterrorism events.  Emerg 
Infect Dis 2002, 8:753-760.
18. Heffernan R, Mostashari F, Das D, Karpati A, Kulldorf M, Weiss D: 
Syndromic surveillance in public health practice, New York City.  Emerg 
Infect Dis 2004, 10:858-864.
19. Tokars JI, Burkom H, Xing J, English R, Bloom S, Cox K, et al.: Enhancing 
time series detection algorithms for automated biosurveillance.  Emerg 
Infect Dis 2009, 15:533-539.
20. Minor P, English R, Tokars J: Representativeness of emergency 
department data reported to the BioSense system.  Paper presented at 
the International Society for Disease Surveillance Conference; December 3--5, 
2008; Raleigh, NC .
21. U.S. Department of Health and Human Services: National Hospital 
Ambulatory Medical Care Survey: 2006 Emergency Department 
Summary: National Health Statistics Reports, Number 7.  2008 [http://
www.cdc.gov/nchs/data/nhsr/nhsr007.pdf]. Hyattsville, MD: USDHHS, 
Centers for Disease Control and Prevention, National Center for Health 
Statistics
22. Centers for Disease Control and Prevention: Monitoring health effects of 
wildfires using the BioSense system--San Diego County, California, 
October 2007.  MMWR 2008, 57(27):741-744.
23. Buehler JW, Whitney EA, Smith D, Prietula MJ, Stanton SH, Isakov AP: 
Situational uses of syndromic surveillance.  Biosecurity and Bioterrorism: 
Biodefense Strategy, Practice, and Science 2009, 7:165-177.
24. Podgornik MN, Postema A, English R, Uhde KB, Bloom S, Hicks P, et al.: The 
influenza data summary: a prototype application for visualizing 
national influenza activity.  In Intelligence and Security Informatics: 
BioSurveillance: Springer Lecture Notes in Computer Science, No. 4506 Edited 
by: Zeng D, Gotham I, Komatsu K, Lynch C, Thurmond M, Madigan, D, et al. 
Berlin Heidelberg: Springer-Verlag; 2007:159-168. 
25. Hales C, English R, McMurray P, Podgornik M, Tokars JI: The BioSense 
influenza module.  Paper presented at the International Society for Disease 
Surveillance Conference; December 3-5 2008; Raleigh, NC .
26. Centers for Disease Control and Prevention: Overview of influenza 
surveillance in the United States.   [http://www.cdc.gov/flu/weekly/pdf/
flu-surveillance-overview.pdf].
27. Centers for Disease Control and Prevention: Advancing Excellence & 
Integrity of CDC Science: Centers of Excellence in Public Health 
Informatics (P01).   [http://www.cdc.gov/od/science/PHResearch/grants/
fy2005_109.htm].
28. Barnett C, Radke S: Evaluating the validity of emergency department 
data for biosurveillance.  Paper presented at the International Society for 
Disease Surveillance Conference; December 2-4, 2009; Miami, FL .
29. Dey AN, Hicks P, Tokars JI: Automated monitoring of injuries due to falls 
using the BioSense system.  Paper presented at the International Society for 
Disease Surveillance Conference; December 3-5, 2008; Raleigh, NC .
30. Rainisch G, Benoit S, Tokars J: Burns reported to the BioSense system 
during the independence day holiday.  Paper presented at the 
International Society for Disease Surveillance Conference; December 3-5, 
2008; Raleigh, NC .
31. Rainisch G, Miller M, Tokars J: National heat-related Illness (HRI) 
surveillance using emergency department data.  Paper presented at the 
International Society for Disease Surveillance Conference; December 2-4, 
2009, Miami, FL .
32. Mohammed S, Phillips K, Rainisch G, Minor P, Tokars J: Automated 
monitoring of asthma using the BioSense system.  Paper presented at the 
Received: 21 October 2009 Accepted: 25 May 2010 
Published: 25 May 2010
This article is available from: http://www.biomedcentral.com/1472-6947/10/30 © 2010 Tokars et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Medical Informatics and Decision Making 2010, 10:30Tokars et al. BMC Medical Informatics and Decision Making 2010, 10:30
http://www.biomedcentral.com/1472-6947/10/30
Page 12 of 12
International Society for Disease Surveillance Conference; December 3-5, 
2008; Raleigh, NC .
33. Rainisch G, Martin C, Tokars J: The use of BioSense data for surveillance 
of gastrointestinal illness.  Paper presented at the International Society for 
Disease Surveillance Conference; October 10-11, 2007; Indianapolis, IN .
34. Rangel M, Lucero C, Oda G, Lombardo J, Akaka L, Holodniy M: Lessons 
learned from the investigation of clusters of influenza-like-illness 
detected at Veterans Affairs (VA) facilities using the Biosense and 
ESSENCE syndromic surveillance systems.  Poster presented at the 
International Society for Disease Surveillance Conference; December 2-4, 
2009, Miami, FL .
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1472-6947/10/30/prepub
doi: 10.1186/1472-6947-10-30
Cite this article as: Tokars et al., Summary of data reported to CDC's national 
automated biosurveillance system, 2008 BMC Medical Informatics and Deci-
sion Making 2010, 10:30